ImmunityBio is a biotechnology company that develops immunotherapies for cancer and infectious diseases. The company's lead product candidate is a cancer vaccine that targets multiple tumor antigens. ImmunityBio was founded in 2015 by Patrick Soon-Shiong, and has raised over $1 billion in funding from investors such as NantWorks and Blackstone Group.